Atlas Trials

Testing a New Anti-cancer Drug Combination, Entinostat and GSK525762C, for Advanced and Refractory Solid Tumors and Lymphomas

Clinical trial NCT03925428 · WITHDRAWN

Trial details

NCT number
NCT03925428
Sponsor
National Cancer Institute (NCI)
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced LymphomaAdvanced Malignant Solid NeoplasmAnn Arbor Stage III B-Cell Non-Hodgkin LymphomaAnn Arbor Stage III T-Cell Non-Hodgkin LymphomaAnn Arbor Stage IV B-Cell Non-Hodgkin LymphomaAnn Arbor Stage IV T-Cell Non-Hodgkin LymphomaRefractory B-Cell Non-Hodgkin LymphomaRefractory LymphomaRefractory Malignant Solid NeoplasmRefractory Pancreatic CarcinomaRefractory T-Cell Non-Hodgkin LymphomaStage II Pancreatic Cancer AJCC v8
Start date
2020-09-18
Primary completion
2020-09-18
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.